1. HIV-1 Remission: Accelerating the Path to Permanent HIV-1 Silencing
- Author
-
Lyons, Danielle E, Kumar, Priti, Roan, Nadia R, Defechereux, Patricia A, Feschotte, Cedric, Lange, Ulrike C, Murthy, Niren, Sameshima, Pauline, Verdin, Eric, Ake, Julie A, Parsons, Matthew S, Nath, Avindra, Gianella, Sara, Smith, Davey M, Kallas, Esper G, Villa, Thomas J, Strange, Richard, Mwesigwa, Betty, O’Brien, Robert L Furler, Nixon, Douglas F, Ndhlovu, Lishomwa C, Valente, Susana T, and Ott, Melanie
- Subjects
Microbiology ,Biological Sciences ,Infectious Diseases ,Genetics ,Sexually Transmitted Infections ,Clinical Research ,HIV/AIDS ,2.2 Factors relating to the physical environment ,Infection ,Humans ,HIV-1 ,Virus Latency ,Proviruses ,Endogenous Retroviruses ,HIV Infections ,HIV Seropositivity ,CD4-Positive T-Lymphocytes ,HIV-1 cure ,latency ,transcriptional silencing ,HERV - Abstract
Despite remarkable progress, a cure for HIV-1 infection remains elusive. Rebound competent latent and transcriptionally active reservoir cells persevere despite antiretroviral therapy and rekindle infection due to inefficient proviral silencing. We propose a novel "block-lock-stop" approach, entailing long term durable silencing of viral expression towards an irreversible transcriptionally inactive latent provirus to achieve long term antiretroviral free control of the virus. A graded transformation of remnant HIV-1 in PLWH from persistent into silent to permanently defective proviruses is proposed, emulating and accelerating the natural path that human endogenous retroviruses (HERVs) take over millions of years. This hypothesis was based on research into delineating the mechanisms of HIV-1 latency, lessons from latency reversing agents and advances of Tat inhibitors, as well as expertise in the biology of HERVs. Insights from elite controllers and the availability of advanced genome engineering technologies for the direct excision of remnant virus set the stage for a rapid path to an HIV-1 cure.
- Published
- 2023